New Zealand Gazette – 2002 – No. 1

Page 52

✨ Fisheries and Health Notices



NEW ZEALAND GAZETTE No. 1

52

to a point off Normanby at 44° 27.5′ S and
171° 16′ E; then proceeding due west to the coast at
44° 27.5′ S and 171° 15.05′ E; then proceeding
northwards along the mean high water mark to the
point of commencement.

  1. Prohibition on use of amateur set nets in the Canterbury set net area—(1) Except as provided in subclause (2), the Minister of Fisheries hereby prohibits any
    person who is not a commercial fisher from using or setting
    any set net within the Canterbury set net area from 1 October
    in any year and ending on 31 March in the following year
    (both dates inclusive).

(2) Despite subclause (1), a person to whom subclause (1)
applies may use or set a set net during the months from
October to March in any year in the Banks Peninsula flounder
area and the South Timaru reef area.

Dated at Wellington this 21st day of December 2001.

PETE HODGSON, Minister of Fisheries.

go359

Health

Medicines Act 1981

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or
use in New Zealand of the new medicine set out in the schedule hereto:

Schedule

Product: Herceptin

Active Ingredient(s): Trastuzumab 150mg

Dosage Form: Powder for infusion

New Zealand Sponsor: Roche Products (New Zealand) Limited

Manufacturer(s): F Hoffmann-La Roche AG, Basel, Switzerland

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 20th day of December 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go194

Renewal of Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or
use in New Zealand of the new medicine set out in the schedule hereto:

Schedule

Product: Viramune

Active Ingredient(s): Nevirapine (hemihydrate) 10.35mg/mL equivalent 10mg/mL nevirapine

Dosage Form: Oral suspension

New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited

Manufacturer(s): Roxane Laboratories Inc, Columbus, Ohio, United States of America

Note: This consent is valid for 2 years from 2 March 2002.

Dated this 20th day of December 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go192

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the schedule hereto:

Schedule

Product: CAPD/DPCA 17 Stay Safe

Active Ingredient(s):

  • Calcium chloride (dihydrate) 0.1838g/L
  • Glucose monohydrate 16.5g/L equivalent to 15g/L glucose anhydrous
  • Magnesium chloride (hexahydrate) 0.1017g/L
  • Sodium chloride 5.786g/L
  • Sodium lactate 3.925g/L

Dosage Form: Dialysis solution

New Zealand Sponsor: Fresenius Medical Care New Zealand

Manufacturer(s): Fresenius Medical Care Deutschland GmbH, St Wendel, Saarland, Germany



Next Page →



Online Sources for this page:

VUW Te Waharoa — PDF NZ Gazette 2002, No 1


Gazette.govt.nz — PDF NZ Gazette 2002, No 1




✨ LLM interpretation of page content

🌾 Fisheries (Canterbury Set Net Area Amateur Prohibition) Notice 2002 (continued from previous page)

🌾 Primary Industries & Resources
21 December 2001
Fisheries, Set Net Prohibition, Canterbury, Banks Peninsula
  • Pete Hodgson, Minister of Fisheries

🏥 Provisional Consent to the Distribution of a New Medicine (Herceptin)

🏥 Health & Social Welfare
20 December 2001
Medicine, Herceptin, Trastuzumab, Roche Products
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Renewal of Provisional Consent to the Distribution of a New Medicine (Viramune)

🏥 Health & Social Welfare
20 December 2001
Medicine, Viramune, Nevirapine, Boehringer Ingelheim
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of New Medicines (CAPD/DPCA 17 Stay Safe)

🏥 Health & Social Welfare
20 December 2001
Medicine, CAPD/DPCA 17 Stay Safe, Dialysis Solution, Fresenius Medical Care
  • G. R. Boyd, Chief Advisor, Safety and Regulation